Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - etoposide 100mg - capsule - 100 mg - active: etoposide 100mg excipient: citric acid monohydrate gelatin glycerol   iron oxide red macrogol 400 propyl hydroxybenzoate sodium ethyl hydroxybenzoate titanium dioxide water  

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - etoposide 50mg - capsule - 50 mg - active: etoposide 50mg excipient: citric acid monohydrate gelatin glycerol   iron oxide red macrogol 400 propyl hydroxybenzoate sodium ethyl hydroxybenzoate titanium dioxide water  

Yeni Zelanda - İngilizce - Ministry for Primary Industries

mitsui & co (nz) limited - thiophanate-methyl - thiophanate-methyl 400 g/litre - fungicide

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agnova technologies pty ltd - ipflufenoquin - suspension concentrate - ipflufenoquin active active 218.0 g/l - fungicide

ABD - İngilizce - NLM (National Library of Medicine)

concordia pharmaceuticals inc. - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide 25 mg - zonegran is indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. zonegran is contraindicated in patients who have demonstrated hypersensitivity to sulfonamides or zonisamide. the abuse and dependence potential of zonegran has not been evaluated in human studies (see warnings, cognitive/neuropsychiatric adverse events subsection). in a series of animal studies, zonisamide did not demonstrate abuse liability and dependence potential. monkeys did not self-administer zonisamide in a standard reinforcing paradigm. rats exposed to zonisamide did not exhibit signs of physical dependence of the cns-depressant type. rats did not generalize the effects of diazepam to zonisamide in a standard discrimination paradigm after training, suggesting that zonisamide does not have abuse potential of the benzodiazepine-cns depressant type.

Singapur - İngilizce - HSA (Health Sciences Authority)

purapharm international (singapore) pte ltd - granules (internal use)

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

nippon-chemiphar co.,ltd - amlodipine besilate; atorvastatin calcium hydrate - light yellow tablet, diameter: 6.6mm, thickness:2.7mm

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

nippon-chemiphar co.,ltd - amlodipine besilate; atorvastatin calcium hydrate - white tablet, diameter: 6.6 mm, thickness: 2.6 mm

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

nippon-chemiphar co.,ltd - amlodipine besilate; atorvastatin calcium hydrate - light yellow tablet, major axis: 8.1mm, minor axis: 4.6mm, thickness: 2.8mm

Japonya - İngilizce - すりの適正使用協議会 RAD-AR Council, Japan

nippon-chemiphar co.,ltd - amlodipine besilate; atorvastatin calcium hydrate - white tablet, major axis: 8.1mm, minor axis: 4.6mm, thickness: 2.9mm